nodes	percent_of_prediction	percent_of_DWPC	metapath
Tofisopam—CYP3A4—Pilocarpine—glaucoma	0.233	0.235	CbGbCtD
Tofisopam—CYP3A4—Brinzolamide—glaucoma	0.183	0.185	CbGbCtD
Tofisopam—CYP3A4—Dorzolamide—glaucoma	0.176	0.178	CbGbCtD
Tofisopam—CYP3A4—Methazolamide—glaucoma	0.157	0.159	CbGbCtD
Tofisopam—CYP3A4—Acetazolamide—glaucoma	0.126	0.127	CbGbCtD
Tofisopam—CYP3A4—Clonidine—glaucoma	0.114	0.115	CbGbCtD
Tofisopam—PDE2A—Nitric oxide stimulates guanylate cyclase—NOS3—glaucoma	0.000777	0.0643	CbGpPWpGaD
Tofisopam—PDE10A—Nitric oxide stimulates guanylate cyclase—NOS3—glaucoma	0.000589	0.0488	CbGpPWpGaD
Tofisopam—PDE3A—Nitric oxide stimulates guanylate cyclase—NOS3—glaucoma	0.000347	0.0287	CbGpPWpGaD
Tofisopam—PDE2A—Platelet homeostasis—NOS3—glaucoma	0.000303	0.0251	CbGpPWpGaD
Tofisopam—CYP3A4—Benzo(a)pyrene metabolism—CYP1B1—glaucoma	0.000246	0.0203	CbGpPWpGaD
Tofisopam—CYP3A4—Aflatoxin B1 metabolism—GSTM1—glaucoma	0.00024	0.0199	CbGpPWpGaD
Tofisopam—PDE2A—GPCR downstream signaling—OPN4—glaucoma	0.000235	0.0195	CbGpPWpGaD
Tofisopam—PDE10A—Platelet homeostasis—NOS3—glaucoma	0.000229	0.019	CbGpPWpGaD
Tofisopam—PDE2A—Signaling by GPCR—OPN4—glaucoma	0.000213	0.0177	CbGpPWpGaD
Tofisopam—PDE2A—GPCR downstream signaling—PTGFR—glaucoma	0.000212	0.0175	CbGpPWpGaD
Tofisopam—PDE2A—Signaling by GPCR—PTGFR—glaucoma	0.000192	0.0159	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—LRP12—glaucoma	0.000182	0.0151	CbGpPWpGaD
Tofisopam—PDE10A—GPCR downstream signaling—OPN4—glaucoma	0.000178	0.0147	CbGpPWpGaD
Tofisopam—PDE2A—Hemostasis—TGFB2—glaucoma	0.000162	0.0134	CbGpPWpGaD
Tofisopam—PDE10A—Signaling by GPCR—OPN4—glaucoma	0.000162	0.0134	CbGpPWpGaD
Tofisopam—PDE10A—GPCR downstream signaling—PTGFR—glaucoma	0.00016	0.0133	CbGpPWpGaD
Tofisopam—PDE10A—Signaling by GPCR—PTGFR—glaucoma	0.000146	0.0121	CbGpPWpGaD
Tofisopam—CYP3A4—Estrogen metabolism—CYP1B1—glaucoma	0.000141	0.0117	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—LRP12—glaucoma	0.000138	0.0114	CbGpPWpGaD
Tofisopam—PDE3A—Platelet homeostasis—NOS3—glaucoma	0.000135	0.0112	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—OPN4—glaucoma	0.000126	0.0104	CbGpPWpGaD
Tofisopam—CYP3A4—Tamoxifen metabolism—CYP1B1—glaucoma	0.000125	0.0103	CbGpPWpGaD
Tofisopam—PDE10A—Hemostasis—TGFB2—glaucoma	0.000123	0.0102	CbGpPWpGaD
Tofisopam—PDE2A—Hemostasis—SOD1—glaucoma	0.000123	0.0102	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—HEYL—glaucoma	0.000117	0.0097	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—PTGFR—glaucoma	0.000114	0.0094	CbGpPWpGaD
Tofisopam—CYP3A4—Estrogen metabolism—GSTM1—glaucoma	0.000113	0.00934	CbGpPWpGaD
Tofisopam—PDE4A—GPCR downstream signaling—OPN4—glaucoma	0.000108	0.00893	CbGpPWpGaD
Tofisopam—PDE3A—GPCR downstream signaling—OPN4—glaucoma	0.000105	0.00869	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—OPN4—glaucoma	9.8e-05	0.00811	CbGpPWpGaD
Tofisopam—PDE4A—GPCR downstream signaling—PTGFR—glaucoma	9.72e-05	0.00804	CbGpPWpGaD
Tofisopam—PDE2A—Signaling by GPCR—SMO—glaucoma	9.69e-05	0.00802	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—OPN4—glaucoma	9.56e-05	0.00791	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—OPN4—glaucoma	9.54e-05	0.00789	CbGpPWpGaD
Tofisopam—PDE3A—GPCR downstream signaling—PTGFR—glaucoma	9.45e-05	0.00782	CbGpPWpGaD
Tofisopam—PDE2A—Hemostasis—MMP1—glaucoma	9.36e-05	0.00774	CbGpPWpGaD
Tofisopam—PDE10A—Hemostasis—SOD1—glaucoma	9.3e-05	0.0077	CbGpPWpGaD
Tofisopam—PDE2A—Hemostasis—CAV1—glaucoma	8.97e-05	0.00742	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—RPTOR—glaucoma	8.89e-05	0.00735	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—HEYL—glaucoma	8.89e-05	0.00735	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—PTGFR—glaucoma	8.83e-05	0.0073	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—NCK2—glaucoma	8.61e-05	0.00712	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—PTGFR—glaucoma	8.61e-05	0.00712	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—PTGFR—glaucoma	8.59e-05	0.0071	CbGpPWpGaD
Tofisopam—PDE2A—Hemostasis—FN1—glaucoma	8.54e-05	0.00707	CbGpPWpGaD
Tofisopam—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	8.49e-05	0.00703	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—LRP12—glaucoma	8.35e-05	0.00691	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—LRP12—glaucoma	8.13e-05	0.00672	CbGpPWpGaD
Tofisopam—PDE10A—Signaling by GPCR—SMO—glaucoma	7.35e-05	0.00608	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—HDAC9—glaucoma	7.32e-05	0.00605	CbGpPWpGaD
Tofisopam—PDE3A—Hemostasis—TGFB2—glaucoma	7.23e-05	0.00598	CbGpPWpGaD
Tofisopam—PDE10A—Hemostasis—MMP1—glaucoma	7.09e-05	0.00587	CbGpPWpGaD
Tofisopam—PDE2A—GPCR downstream signaling—EDN1—glaucoma	7.04e-05	0.00582	CbGpPWpGaD
Tofisopam—PDE10A—Hemostasis—CAV1—glaucoma	6.8e-05	0.00563	CbGpPWpGaD
Tofisopam—PDE2A—Hemostasis—NOS3—glaucoma	6.78e-05	0.00561	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—RPTOR—glaucoma	6.73e-05	0.00557	CbGpPWpGaD
Tofisopam—CYP3A4—Tryptophan metabolism—CYP1B1—glaucoma	6.67e-05	0.00552	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—NCK2—glaucoma	6.52e-05	0.0054	CbGpPWpGaD
Tofisopam—PDE10A—Hemostasis—FN1—glaucoma	6.47e-05	0.00536	CbGpPWpGaD
Tofisopam—PDE2A—Signaling by GPCR—EDN1—glaucoma	6.39e-05	0.00529	CbGpPWpGaD
Tofisopam—PDE2A—GPCR downstream signaling—C3—glaucoma	6.15e-05	0.00509	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—OPN4—glaucoma	5.79e-05	0.00479	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—SMO—glaucoma	5.73e-05	0.00474	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—OPN4—glaucoma	5.63e-05	0.00466	CbGpPWpGaD
Tofisopam—PDE2A—Signaling by GPCR—C3—glaucoma	5.58e-05	0.00462	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—HDAC9—glaucoma	5.55e-05	0.00459	CbGpPWpGaD
Tofisopam—PDE3A—Hemostasis—SOD1—glaucoma	5.48e-05	0.00454	CbGpPWpGaD
Tofisopam—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	5.39e-05	0.00446	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—HEYL—glaucoma	5.38e-05	0.00445	CbGpPWpGaD
Tofisopam—PDE10A—GPCR downstream signaling—EDN1—glaucoma	5.33e-05	0.00441	CbGpPWpGaD
Tofisopam—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—glaucoma	5.32e-05	0.0044	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—NTRK2—glaucoma	5.24e-05	0.00433	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—HEYL—glaucoma	5.24e-05	0.00433	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—PTGFR—glaucoma	5.21e-05	0.00431	CbGpPWpGaD
Tofisopam—PDE10A—Hemostasis—NOS3—glaucoma	5.14e-05	0.00425	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—PTGFR—glaucoma	5.07e-05	0.0042	CbGpPWpGaD
Tofisopam—PDE2A—Hemostasis—VEGFA—glaucoma	4.89e-05	0.00404	CbGpPWpGaD
Tofisopam—PDE10A—Signaling by GPCR—EDN1—glaucoma	4.84e-05	0.00401	CbGpPWpGaD
Tofisopam—PDE10A—GPCR downstream signaling—C3—glaucoma	4.66e-05	0.00386	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—NGFR—glaucoma	4.49e-05	0.00372	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—SMO—glaucoma	4.45e-05	0.00368	CbGpPWpGaD
Tofisopam—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	4.37e-05	0.00362	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—SMO—glaucoma	4.34e-05	0.00359	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—SMO—glaucoma	4.33e-05	0.00358	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—NTRK1—glaucoma	4.27e-05	0.00353	CbGpPWpGaD
Tofisopam—PDE10A—Signaling by GPCR—C3—glaucoma	4.23e-05	0.0035	CbGpPWpGaD
Tofisopam—PDE3A—Hemostasis—MMP1—glaucoma	4.18e-05	0.00346	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—RPTOR—glaucoma	4.08e-05	0.00338	CbGpPWpGaD
Tofisopam—PDE3A—Hemostasis—CAV1—glaucoma	4.01e-05	0.00332	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—NTRK2—glaucoma	3.97e-05	0.00328	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—RPTOR—glaucoma	3.97e-05	0.00328	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—NCK2—glaucoma	3.95e-05	0.00327	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—CDKN2B—glaucoma	3.93e-05	0.00326	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—NCK2—glaucoma	3.84e-05	0.00318	CbGpPWpGaD
Tofisopam—PDE3A—Hemostasis—FN1—glaucoma	3.81e-05	0.00316	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—EDN1—glaucoma	3.77e-05	0.00312	CbGpPWpGaD
Tofisopam—PDE10A—Hemostasis—VEGFA—glaucoma	3.7e-05	0.00307	CbGpPWpGaD
Tofisopam—PDE2A—Hemostasis—TP53—glaucoma	3.69e-05	0.00306	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—NGF—glaucoma	3.47e-05	0.00287	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—NGFR—glaucoma	3.4e-05	0.00282	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—HDAC9—glaucoma	3.36e-05	0.00278	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—C3—glaucoma	3.3e-05	0.00273	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—HDAC9—glaucoma	3.27e-05	0.0027	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—NTRK1—glaucoma	3.24e-05	0.00268	CbGpPWpGaD
Tofisopam—PDE4A—GPCR downstream signaling—EDN1—glaucoma	3.23e-05	0.00267	CbGpPWpGaD
Tofisopam—PDE3A—GPCR downstream signaling—EDN1—glaucoma	3.14e-05	0.0026	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—APOE—glaucoma	3.07e-05	0.00254	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—CAV1—glaucoma	3.04e-05	0.00252	CbGpPWpGaD
Tofisopam—PDE3A—Hemostasis—NOS3—glaucoma	3.03e-05	0.00251	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—CDKN2B—glaucoma	2.98e-05	0.00247	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—EDN1—glaucoma	2.93e-05	0.00243	CbGpPWpGaD
Tofisopam—CYP3A4—Biological oxidations—GSTT1—glaucoma	2.91e-05	0.00241	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—FN1—glaucoma	2.9e-05	0.0024	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—BAD—glaucoma	2.86e-05	0.00237	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—EDN1—glaucoma	2.86e-05	0.00237	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—EDN1—glaucoma	2.85e-05	0.00236	CbGpPWpGaD
Tofisopam—PDE4A—GPCR downstream signaling—C3—glaucoma	2.82e-05	0.00234	CbGpPWpGaD
Tofisopam—PDE10A—Hemostasis—TP53—glaucoma	2.8e-05	0.00232	CbGpPWpGaD
Tofisopam—PDE3A—GPCR downstream signaling—C3—glaucoma	2.75e-05	0.00227	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—SMO—glaucoma	2.63e-05	0.00218	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—NGF—glaucoma	2.63e-05	0.00218	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—C3—glaucoma	2.56e-05	0.00212	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—SMO—glaucoma	2.56e-05	0.00212	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—C3—glaucoma	2.5e-05	0.00207	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—C3—glaucoma	2.49e-05	0.00206	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—NTRK2—glaucoma	2.4e-05	0.00199	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—NTRK2—glaucoma	2.34e-05	0.00194	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—APOE—glaucoma	2.33e-05	0.00193	CbGpPWpGaD
Tofisopam—CYP3A4—Biological oxidations—CYP1B1—glaucoma	2.32e-05	0.00192	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—CAV1—glaucoma	2.31e-05	0.00191	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—NOS3—glaucoma	2.3e-05	0.0019	CbGpPWpGaD
Tofisopam—CYP3A4—Metapathway biotransformation—CYP1B1—glaucoma	2.29e-05	0.00189	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—FN1—glaucoma	2.19e-05	0.00182	CbGpPWpGaD
Tofisopam—PDE3A—Hemostasis—VEGFA—glaucoma	2.18e-05	0.00181	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—BAD—glaucoma	2.17e-05	0.00179	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—NGFR—glaucoma	2.06e-05	0.00171	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—CA5A—glaucoma	2.04e-05	0.00169	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—NARFL—glaucoma	2.04e-05	0.00169	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—NGFR—glaucoma	2.01e-05	0.00166	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—CDKN1B—glaucoma	1.99e-05	0.00165	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—NTRK1—glaucoma	1.96e-05	0.00162	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—NTRK1—glaucoma	1.91e-05	0.00158	CbGpPWpGaD
Tofisopam—CYP3A4—Biological oxidations—GSTM1—glaucoma	1.86e-05	0.00154	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—MMP9—glaucoma	1.85e-05	0.00153	CbGpPWpGaD
Tofisopam—CYP3A4—Metapathway biotransformation—GSTM1—glaucoma	1.83e-05	0.00151	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—CDKN2B—glaucoma	1.81e-05	0.00149	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—CDKN2B—glaucoma	1.76e-05	0.00145	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—NOS3—glaucoma	1.74e-05	0.00144	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—EDN1—glaucoma	1.73e-05	0.00143	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—EDN1—glaucoma	1.69e-05	0.0014	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—VEGFA—glaucoma	1.66e-05	0.00137	CbGpPWpGaD
Tofisopam—PDE3A—Hemostasis—TP53—glaucoma	1.65e-05	0.00136	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—NGF—glaucoma	1.59e-05	0.00132	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—NGF—glaucoma	1.55e-05	0.00128	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—C3—glaucoma	1.51e-05	0.00125	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—CDKN1B—glaucoma	1.51e-05	0.00125	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—C3—glaucoma	1.47e-05	0.00122	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—APOE—glaucoma	1.41e-05	0.00117	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—MMP9—glaucoma	1.4e-05	0.00116	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—CAV1—glaucoma	1.4e-05	0.00116	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—APOE—glaucoma	1.37e-05	0.00113	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—CAV1—glaucoma	1.36e-05	0.00112	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—FN1—glaucoma	1.33e-05	0.0011	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—BAD—glaucoma	1.31e-05	0.00109	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—FN1—glaucoma	1.29e-05	0.00107	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—BAD—glaucoma	1.28e-05	0.00106	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—VEGFA—glaucoma	1.26e-05	0.00104	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—TP53—glaucoma	1.25e-05	0.00104	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—NOS3—glaucoma	1.06e-05	0.000874	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—NOS3—glaucoma	1.03e-05	0.00085	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—CA1—glaucoma	9.97e-06	0.000825	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—CTSA—glaucoma	9.66e-06	0.000799	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—TP53—glaucoma	9.49e-06	0.000785	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—CDKN1B—glaucoma	9.15e-06	0.000757	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—CA2—glaucoma	9.12e-06	0.000755	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—CDKN1B—glaucoma	8.9e-06	0.000736	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—MMP9—glaucoma	8.47e-06	0.000701	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—MMP9—glaucoma	8.24e-06	0.000682	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—VEGFA—glaucoma	7.61e-06	0.00063	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—VEGFA—glaucoma	7.4e-06	0.000612	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—TXN—glaucoma	6.42e-06	0.000532	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—TP53—glaucoma	5.75e-06	0.000476	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—TP53—glaucoma	5.59e-06	0.000463	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—GSTT1—glaucoma	4.98e-06	0.000412	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—ABCA1—glaucoma	3.97e-06	0.000328	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—CYP1B1—glaucoma	3.97e-06	0.000328	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—GSTM1—glaucoma	3.17e-06	0.000263	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—MTHFR—glaucoma	2.8e-06	0.000232	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—APOE—glaucoma	2.61e-06	0.000216	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—CAV1—glaucoma	2.59e-06	0.000214	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—NOS3—glaucoma	1.96e-06	0.000162	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—PTGS2—glaucoma	1.79e-06	0.000148	CbGpPWpGaD
